{"disease":{"id":"fall","name":"fall"},"drugs":{"marketed":[{"drug_id":"bevacizumab","indication_name":"Malignant tumor of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avastin","generic_name":"bevacizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":82,"revenue":"2100","mechanism":"Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors."},{"drug_id":"niraparib","indication_name":"Carcinoma in situ of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zejula","generic_name":"niraparib","company_name":"GSK","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 2","drug_class":"Poly(ADP-Ribose) Polymerase Inhibitor","quality_score":69,"revenue":"600","mechanism":"Zejula works by blocking the action of an enzyme called PARP, which helps repair damaged DNA in cancer cells."},{"drug_id":"nab-paclitaxel","indication_name":"Carcinoma of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"nab-paclitaxel","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor","quality_score":57,"revenue":"368","mechanism":""},{"drug_id":"nabpaclitaxel","indication_name":"Carcinoma of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"Nabpaclitaxel","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor","quality_score":null,"revenue":"368","mechanism":"Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division."},{"drug_id":"paclitaxel","indication_name":"Carcinoma of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"paclitaxel","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor [EPC]","quality_score":76,"revenue":"368","mechanism":""},{"drug_id":"alprostadil","indication_name":"Tetralogy of Fallot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caverject","generic_name":"ALPROSTADIL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP3 subtype","drug_class":"Prostaglandin Analog [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"pf-07059013","indication_name":"Treatment of certain types of fallopian tube cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07059013","generic_name":"pf-07059013","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"abraxane","indication_name":"Carcinoma of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Abraxane","company_name":"The First Affiliated Hospital with Nanjing Medical University","drug_phase":"marketed","molecular_target":"Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prostavasin","indication_name":"Tetralogy of Fallot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prostavasin","company_name":"Hannover Medical School","drug_phase":"phase_2","molecular_target":"Cation channel sperm-associated protein 1, Cation channel sperm-associated protein 2, Cation channel sperm-associated protein 3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"taxol","indication_name":"Carcinoma of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Taxol","company_name":"M.D. Anderson Cancer Center","drug_phase":"marketed","molecular_target":"Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bevacizumab-maly","indication_name":"Platinum-Resistant Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ALYMSYS","generic_name":"BEVACIZUMAB-MALY","company_name":"AMNEAL PHARMS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"air-polymer-type-a","indication_name":"Assessing fallopian tube patency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exem Foam Kit","generic_name":"AIR POLYMER-TYPE A","company_name":"Giskit","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":29,"revenue":null,"mechanism":"Exem Foam Kit works by creating a foam that helps to visualize the female reproductive organs during medical imaging procedures."},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic fallopian tube cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"avastin","indication_name":"Malignant tumor of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Avastin","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"zirabev","indication_name":"Malignant tumor of fallopian tube","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bevacizumab","generic_name":"Bevacizumab-Bvzr","company_name":"Roche","drug_phase":"marketed","molecular_target":"Vascular Endothelial Growth Factor (VEGF)","drug_class":"Monoclonal antibody","quality_score":10,"revenue":null,"mechanism":"Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR."}],"pipeline":[{"drug_id":"endocrine-therapy-1","indication_name":"HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endocrine Therapy 1","generic_name":"endocrine-therapy-1","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Endocrine Therapy 1","quality_score":null,"revenue":null,"mechanism":"Endocrine Therapy 1"},{"drug_id":"endocrine-therapy-2","indication_name":"HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endocrine Therapy 2","generic_name":"endocrine-therapy-2","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Endocrine Therapy 2","quality_score":null,"revenue":null,"mechanism":"Endocrine Therapy 2"},{"drug_id":"pf-06873600","indication_name":"HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-06873600","generic_name":"pf-06873600","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"PF-06873600 tablet for oral dosing","quality_score":null,"revenue":null,"mechanism":"PF-06873600 tablet for oral dosing"}],"offLabel":[],"totalMarketed":15,"totalPipeline":3},"trials":{"data":[{"nct_id":"NCT07181993","title":"The Impact of PRISCUS Medication on Fall Risks","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":932912,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT05680714","title":"Does the New Fall- and Fracture Prevention Initiative in Oslo Have Effect?","phase":"","overall_status":"UNKNOWN","enrollment_count":121000,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT07150754","title":"Cardiological Drug Classes And Falls in Older Adults","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT05628467","title":"Association Between Antidepressant Use and Falls in Older Adults: Analysis of the World Health Organization Global Database","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT02425345","title":"Women's Health Initiative Strong and Healthy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":49331,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT03499717","title":"Generalizability and Spread of an Evidenced-based Fall Prevention Toolkit: Fall TIPS","phase":"","overall_status":"COMPLETED","enrollment_count":37231,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03991806","title":"Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT07028463","title":"ALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20700,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05912972","title":"Development and Management of Registry in Patients With Gynecologic Cancer in Korea","phase":"","overall_status":"RECRUITING","enrollment_count":13500,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03978650","title":"Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT04993781","title":"Electronic Strategies for Tailored Exercise to Prevent FallS","phase":"NA","overall_status":"COMPLETED","enrollment_count":11945,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05654909","title":"Prehospital Assessment Units - a Matched Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":10849,"lead_sponsor_name":"Prehospital Center, Region Zealand","has_results":false},{"nct_id":"NCT07513805","title":"Implementation of Routine Walking Speed Measurements in Older Veterans","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10500,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05906095","title":"Pragmatic Trial to Increase Quality of Care in State Veterans Homes","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10160,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT06768008","title":"An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT03147521","title":"Accidental Falls Care Bundle","phase":"NA","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07406074","title":"Duke Virtual IntEgrated Workflow","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04288596","title":"Canadian Adult Congenital Heart Disease Intervention Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":9000,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04044924","title":"Geriatric Head Trauma Short Term Outcomes Project","phase":"","overall_status":"COMPLETED","enrollment_count":5387,"lead_sponsor_name":"Florida Atlantic University","has_results":false},{"nct_id":"NCT06223763","title":"SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT03745755","title":"Derivation of a Clinical Decision Rule for Emergency Department Head CT Scanning in Seniors Who Have Fallen","phase":"","overall_status":"COMPLETED","enrollment_count":4308,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT07536906","title":"Falls Validation Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Dr. Kerstin de Wit","has_results":false},{"nct_id":"NCT06304428","title":"Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3780,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03354468","title":"The Effects of a Fall Prevention Program on Falls, Patient Safety Culture and Patient-perceived Safety","phase":"","overall_status":"COMPLETED","enrollment_count":3143,"lead_sponsor_name":"Helse Møre og Romsdal HF","has_results":false},{"nct_id":"NCT06327893","title":"Patients Treated by the Danish Emergency Medical Services Following Non-drowning Water Rescues From 2016 to 2023","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Prehospital Center, Region Zealand","has_results":false},{"nct_id":"NCT05564377","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":2900,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02835989","title":"Community Paramedicine at Home","phase":"NA","overall_status":"COMPLETED","enrollment_count":2826,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05689554","title":"Reducing CNS-Active Medications to Prevent Falls and Injuries in Older Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":2367,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT03112109","title":"SMARTCARE Project: Deploying Integrated Health & Social Services for Independent Living by Older People","phase":"","overall_status":"COMPLETED","enrollment_count":2111,"lead_sponsor_name":"Him SA","has_results":false},{"nct_id":"NCT03879902","title":"The Characteristics of Falls and Its Potential Predictors","phase":"","overall_status":"COMPLETED","enrollment_count":2101,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06295965","title":"Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT01139957","title":"Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1916,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":false},{"nct_id":"NCT06984978","title":"EXpress Prevent Rural oldEr Adults' fallS, fractureS and Dependency (EXPRESS)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1881,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03870867","title":"The Emergency Department Falls Study","phase":"","overall_status":"COMPLETED","enrollment_count":1753,"lead_sponsor_name":"Hamilton Health Sciences Corporation","has_results":false},{"nct_id":"NCT03963570","title":"The Effectiveness of a Self-managed Digital Exercise Programme to Prevent Falls in Older Community-dwelling People","phase":"NA","overall_status":"COMPLETED","enrollment_count":1628,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT04314401","title":"National Cancer Institute \"Cancer Moonshot Biobank\"","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06659484","title":"Health Data from Well on My Legs Program","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT00951496","title":"Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1560,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06310486","title":"The Emergency Call on Drowning","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Prehospital Center, Region Zealand","has_results":false},{"nct_id":"NCT06310525","title":"Using Machine Learning to Optimise the Danish Drowning Formula","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Prehospital Center, Region Zealand","has_results":false},{"nct_id":"NCT04027868","title":"Genomic BRCA and Extensive ovArian Cancer Testing","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"ARCAGY/ GINECO GROUP","has_results":false},{"nct_id":"NCT04277000","title":"Determinants of the Fall Risk Profile and Quality of Life of Older Subjects Visting Climatic Health Resorts","phase":"","overall_status":"COMPLETED","enrollment_count":1471,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03602859","title":"A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Tesaro, Inc.","has_results":true},{"nct_id":"NCT03740165","title":"Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1367,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03038100","title":"A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1301,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06965660","title":"Population Cohort Set-up for the Epidemiological Assessment of Balance Disorders in Elderly People","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1300,"lead_sponsor_name":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","has_results":false},{"nct_id":"NCT05693480","title":"Development and Applications of Daily-use Fall Risk Assessment Device to Prevent Elderly People From Falling","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1300,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT05198193","title":"Evaluation and Development of Falls Prevention and Management in the Community for Older Adults","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT05712252","title":"Fall, Fracture and Frailty","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT00108745","title":"Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1157,"lead_sponsor_name":"GOG Foundation","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}